ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Engelen, M.P.K.J.
Right arrow Articles by Schols, A.M.W.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Engelen, M.P.K.J.
Right arrow Articles by Schols, A.M.W.J.
Eur Respir J 2004; 23:545-551
Copyright ©ERS Journals Ltd 2004


Glutathione and glutamate levels in the diaphragm of patients with chronic obstructive pulmonary disease

M.P.K.J. Engelen1, M. Orozco-Levi3, N.E.P. Deutz2, E. Barreiro3, N. Hernández3, E.F.M. Wouters1, J. Gea3 and A.M.W.J. Schols1

1 Depts of Respiratory Medicine and 2 Surgery, University Hospital Maastricht, Maastricht, the Netherlands. 3 Muscle Research Unit, Municipal Institute of Medical Research, Experimental Studies Centre, Pompeu Fabra University, Barcelona, Spain

CORRESPONDENCE: M.P.K.J. Engelen, Dept of Respiratory Medicine, University Hospital Maastricht, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands. Fax: 31 43 3875051. E-mail: M.Engelen@Pul.Unimaas.NL

Keywords: Chronic obstructive pulmonary disease, diaphragm, glutamate, glutathione

Received: February 28, 2003
Accepted November 25, 2003

This study was supported by grants BMH4-CT98-3406 and QLK6-CT-2000-00417 from the European Union, FIS 01/1324 (Spain) and a University Hospital Maastricht (Maastricht, the Netherlands) research grant.

Recently, decreased glutamate (Glu) and reduced glutathione (GSH) levels were reported in the quadriceps femoris of patients with chronic obstructive pulmonary disease (COPD). The aim of the present study was to investigate whether Glu and GSH levels are also modified in the diaphragm of these patients.

Nine male COPD patients (forced expiratory volume in one second (FEV1) range 28–68% of the predicted value) and seven male patients with normal pulmonary function (mean±sd FEV1 86±3% pred) submitted to thoracotomy were included. Biopsy specimens were taken from the diaphragm (both groups) and the quadriceps femoris (COPD group alone) in order to assess fibre size, myosin heavy chain expression, GSH levels and amino acid profile.

The COPD group was characterised by preserved fibre size, a higher proportion of type I fibres (mean±sem 70±3 versus 26±4%), and higher Glu and GSH content in the diaphragm compared to the quadriceps muscle. However, Glu and GSH levels were similar in diaphragm from the COPD and control groups. Glu level correlated with GSH level in both muscles. No significant correlation was found between Glu or GSH level and fibre size or proportions.

This study shows that glutamate and reduced glutathione levels are preserved in the diaphragm of chronic obstructive pulmonary disease patients. Alterations in glutamate and reduced glutathione metabolism are muscle-specific in chronic obstructive pulmonary disease, affecting the quadriceps femoris but not the diaphragm. Glutamate and reduced glutathione levels are strongly interrelated in both muscles, independent of fibre type distribution and fibre size.




This article has been cited by other articles:


Home page
ThoraxHome page
H. R Gosker, M. P Zeegers, E. F M Wouters, and A. M W J Schols
Muscle fibre type shifting in the vastus lateralis of patients with COPD is associated with disease severity: a systematic review and meta-analysis
Thorax, November 1, 2007; 62(11): 944 - 949.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
C. A. C. Ottenheijm, L. M. A. Heunks, and P. N. R. Dekhuijzen
Diaphragm Muscle Fiber Dysfunction in Chronic Obstructive Pulmonary Disease: Toward a Pathophysiological Concept
Am. J. Respir. Crit. Care Med., June 15, 2007; 175(12): 1233 - 1240.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
S. Jelic and T. H. Le Jemtel
Diagnostic Usefulness of B-Type Natriuretic Peptide and Functional Consequences of Muscle Alterations in COPD and Chronic Heart Failure.
Chest, October 1, 2006; 130(4): 1220 - 1230.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
E. F. M. Wouters
Local and Systemic Inflammation in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, April 1, 2005; 2(1): 26 - 33.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
M. Doucet, R. Debigare, D.R. Joanisse, C. Cote, P. LeBlanc, J. Gregoire, J. Deslauriers, R. Vaillancourt, and F. Maltais
Adaptation of the diaphragm and the vastus lateralis in mild-to-moderate COPD
Eur. Respir. J., December 1, 2004; 24(6): 971 - 979.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the European Respiratory Society.